Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial

Author:

Ebrahimi Parnia,Seyedmirzaei Homa,Moradi Kamyar,Bagheri Sayna,Moeini Mahdi,Mohammadi Mohammad-Reza,Akhondzadeh Shahin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference31 articles.

1. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.;JAMA,2013b

2. Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.;Abdallah;CNS Neurosci Ther,2021

3. The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes.;Aman;Am J Ment Retard,1995

4. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.;Aman;Am J Ment Defic,1985

5. Does pregnenolone adjunct to risperidone ameliorate irritable behavior in adolescents with autism spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial?;Ayatollahi;Clin Neuropharmacol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3